nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—Lisinopril—dilated cardiomyopathy	0.36	1	CrCtD
Ramipril—ACE—dilated cardiomyopathy	0.158	1	CbGaD
Ramipril—ACE—Lisinopril—dilated cardiomyopathy	0.131	0.714	CbGbCtD
Ramipril—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0524	0.286	CbGbCtD
Ramipril—Fosinopril—Lisinopril—dilated cardiomyopathy	0.0387	0.158	CrCrCtD
Ramipril—Moexipril—Lisinopril—dilated cardiomyopathy	0.0291	0.119	CrCrCtD
Ramipril—Cilazapril—Lisinopril—dilated cardiomyopathy	0.0251	0.103	CrCrCtD
Ramipril—Spirapril—Lisinopril—dilated cardiomyopathy	0.0251	0.103	CrCrCtD
Ramipril—Enalapril—Lisinopril—dilated cardiomyopathy	0.0236	0.0962	CrCrCtD
Ramipril—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0236	0.0962	CrCrCtD
Ramipril—Nateglinide—Lisinopril—dilated cardiomyopathy	0.021	0.0858	CrCrCtD
Ramipril—Aspartame—Lisinopril—dilated cardiomyopathy	0.02	0.0814	CrCrCtD
Ramipril—Quinapril—Lisinopril—dilated cardiomyopathy	0.02	0.0814	CrCrCtD
Ramipril—Benazepril—Lisinopril—dilated cardiomyopathy	0.019	0.0776	CrCrCtD
Ramipril—ACE—pulmonary artery—dilated cardiomyopathy	0.00237	0.324	CbGeAlD
Ramipril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.0023	0.315	CbGeAlD
Ramipril—Pemphigoid—Furosemide—dilated cardiomyopathy	0.00202	0.0538	CcSEcCtD
Ramipril—ACE—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00169	0.246	CbGpPWpGaD
Ramipril—ACE—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00132	0.191	CbGpPWpGaD
Ramipril—Pulmonary eosinophilia—Lisinopril—dilated cardiomyopathy	0.00104	0.0277	CcSEcCtD
Ramipril—Pemphigus—Lisinopril—dilated cardiomyopathy	0.000992	0.0264	CcSEcCtD
Ramipril—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.000838	0.0223	CcSEcCtD
Ramipril—ACE—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000712	0.103	CbGpPWpGaD
Ramipril—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.000706	0.0188	CcSEcCtD
Ramipril—Infarction—Lisinopril—dilated cardiomyopathy	0.000685	0.0182	CcSEcCtD
Ramipril—ACE—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000547	0.0793	CbGpPWpGaD
Ramipril—ACE—cardiac ventricle—dilated cardiomyopathy	0.000492	0.0673	CbGeAlD
Ramipril—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000477	0.0127	CcSEcCtD
Ramipril—ACE—myocardium—dilated cardiomyopathy	0.000463	0.0633	CbGeAlD
Ramipril—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.000417	0.0111	CcSEcCtD
Ramipril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.000404	0.0586	CbGpPWpGaD
Ramipril—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.000394	0.0105	CcSEcCtD
Ramipril—ACE—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000385	0.0558	CbGpPWpGaD
Ramipril—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.000377	0.01	CcSEcCtD
Ramipril—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.000366	0.00975	CcSEcCtD
Ramipril—BCHE—cardiac ventricle—dilated cardiomyopathy	0.000363	0.0497	CbGeAlD
Ramipril—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.000339	0.00903	CcSEcCtD
Ramipril—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.000327	0.00871	CcSEcCtD
Ramipril—ACE—heart—dilated cardiomyopathy	0.000323	0.0442	CbGeAlD
Ramipril—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000305	0.00811	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000305	0.00811	CcSEcCtD
Ramipril—Psoriasis—Lisinopril—dilated cardiomyopathy	0.000303	0.00806	CcSEcCtD
Ramipril—Gastritis—Spironolactone—dilated cardiomyopathy	0.000299	0.00797	CcSEcCtD
Ramipril—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.000293	0.00779	CcSEcCtD
Ramipril—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000289	0.00771	CcSEcCtD
Ramipril—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000289	0.00768	CcSEcCtD
Ramipril—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.000282	0.0075	CcSEcCtD
Ramipril—SLC15A2—heart—dilated cardiomyopathy	0.000282	0.0385	CbGeAlD
Ramipril—ACE—cardiac atrium—dilated cardiomyopathy	0.000276	0.0378	CbGeAlD
Ramipril—Drug interaction—Furosemide—dilated cardiomyopathy	0.000273	0.00728	CcSEcCtD
Ramipril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000269	0.00717	CcSEcCtD
Ramipril—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000266	0.00709	CcSEcCtD
Ramipril—Vasculitis—Furosemide—dilated cardiomyopathy	0.00026	0.00692	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000258	0.00688	CcSEcCtD
Ramipril—Renal failure—Spironolactone—dilated cardiomyopathy	0.000256	0.00682	CcSEcCtD
Ramipril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000243	0.00648	CcSEcCtD
Ramipril—BCHE—heart—dilated cardiomyopathy	0.000239	0.0326	CbGeAlD
Ramipril—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000229	0.00611	CcSEcCtD
Ramipril—Urine output increased—Furosemide—dilated cardiomyopathy	0.000229	0.0061	CcSEcCtD
Ramipril—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000227	0.00604	CcSEcCtD
Ramipril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000221	0.00589	CcSEcCtD
Ramipril—Fosinopril—ACE—dilated cardiomyopathy	0.00022	0.135	CrCbGaD
Ramipril—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000217	0.00576	CcSEcCtD
Ramipril—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000217	0.00576	CcSEcCtD
Ramipril—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000214	0.00568	CcSEcCtD
Ramipril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00021	0.00558	CcSEcCtD
Ramipril—Polyuria—Furosemide—dilated cardiomyopathy	0.00021	0.00558	CcSEcCtD
Ramipril—Cough increased—Lisinopril—dilated cardiomyopathy	0.000208	0.00553	CcSEcCtD
Ramipril—Alopecia—Spironolactone—dilated cardiomyopathy	0.000207	0.00551	CcSEcCtD
Ramipril—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000206	0.00548	CcSEcCtD
Ramipril—Deafness—Furosemide—dilated cardiomyopathy	0.000206	0.00548	CcSEcCtD
Ramipril—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000205	0.00546	CcSEcCtD
Ramipril—BCHE—cardiac atrium—dilated cardiomyopathy	0.000204	0.0279	CbGeAlD
Ramipril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000204	0.00543	CcSEcCtD
Ramipril—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000202	0.00539	CcSEcCtD
Ramipril—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.0002	0.00532	CcSEcCtD
Ramipril—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000196	0.00521	CcSEcCtD
Ramipril—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000195	0.00519	CcSEcCtD
Ramipril—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000195	0.00519	CcSEcCtD
Ramipril—BCHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.000193	0.0279	CbGpPWpGaD
Ramipril—Purpura—Furosemide—dilated cardiomyopathy	0.000191	0.00508	CcSEcCtD
Ramipril—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00019	0.00506	CcSEcCtD
Ramipril—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000189	0.00503	CcSEcCtD
Ramipril—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000185	0.00492	CcSEcCtD
Ramipril—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000185	0.00492	CcSEcCtD
Ramipril—Malaise—Spironolactone—dilated cardiomyopathy	0.000184	0.00489	CcSEcCtD
Ramipril—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000182	0.00485	CcSEcCtD
Ramipril—Perindopril—ACE—dilated cardiomyopathy	0.00018	0.11	CrCbGaD
Ramipril—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00018	0.00478	CcSEcCtD
Ramipril—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000179	0.00475	CcSEcCtD
Ramipril—Spirapril—ACE—dilated cardiomyopathy	0.000178	0.109	CrCbGaD
Ramipril—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000172	0.00459	CcSEcCtD
Ramipril—Discomfort—Spironolactone—dilated cardiomyopathy	0.000171	0.00456	CcSEcCtD
Ramipril—Moexipril—ACE—dilated cardiomyopathy	0.00017	0.104	CrCbGaD
Ramipril—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00017	0.00453	CcSEcCtD
Ramipril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000168	0.00447	CcSEcCtD
Ramipril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000168	0.00446	CcSEcCtD
Ramipril—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000166	0.00443	CcSEcCtD
Ramipril—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000166	0.00441	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000166	0.00441	CcSEcCtD
Ramipril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000163	0.00433	CcSEcCtD
Ramipril—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00016	0.00425	CcSEcCtD
Ramipril—Quinapril—ACE—dilated cardiomyopathy	0.000158	0.0971	CrCbGaD
Ramipril—Lisinopril—ACE—dilated cardiomyopathy	0.000158	0.0971	CrCbGaD
Ramipril—Cilazapril—ACE—dilated cardiomyopathy	0.000158	0.0971	CrCbGaD
Ramipril—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000157	0.00419	CcSEcCtD
Ramipril—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000157	0.00419	CcSEcCtD
Ramipril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000156	0.00415	CcSEcCtD
Ramipril—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000156	0.00415	CcSEcCtD
Ramipril—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000154	0.00409	CcSEcCtD
Ramipril—Trandolapril—ACE—dilated cardiomyopathy	0.000153	0.0941	CrCbGaD
Ramipril—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000153	0.00407	CcSEcCtD
Ramipril—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000152	0.00404	CcSEcCtD
Ramipril—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00015	0.00398	CcSEcCtD
Ramipril—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000149	0.00396	CcSEcCtD
Ramipril—Somnolence—Spironolactone—dilated cardiomyopathy	0.000148	0.00393	CcSEcCtD
Ramipril—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000146	0.00388	CcSEcCtD
Ramipril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000145	0.00387	CcSEcCtD
Ramipril—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000145	0.00386	CcSEcCtD
Ramipril—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000144	0.00382	CcSEcCtD
Ramipril—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000143	0.0038	CcSEcCtD
Ramipril—Arthritis—Lisinopril—dilated cardiomyopathy	0.000142	0.00378	CcSEcCtD
Ramipril—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000141	0.00377	CcSEcCtD
Ramipril—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000141	0.00375	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000141	0.00374	CcSEcCtD
Ramipril—Renal failure—Furosemide—dilated cardiomyopathy	0.000139	0.00371	CcSEcCtD
Ramipril—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000139	0.00369	CcSEcCtD
Ramipril—Benazepril—ACE—dilated cardiomyopathy	0.000138	0.0845	CrCbGaD
Ramipril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000137	0.00365	CcSEcCtD
Ramipril—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000137	0.00365	CcSEcCtD
Ramipril—Sweating—Furosemide—dilated cardiomyopathy	0.000136	0.00362	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000134	0.0195	CbGpPWpGaD
Ramipril—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000134	0.00357	CcSEcCtD
Ramipril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000132	0.00352	CcSEcCtD
Ramipril—Urticaria—Spironolactone—dilated cardiomyopathy	0.000132	0.00352	CcSEcCtD
Ramipril—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000131	0.0035	CcSEcCtD
Ramipril—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000129	0.00344	CcSEcCtD
Ramipril—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000126	0.00336	CcSEcCtD
Ramipril—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000125	0.00332	CcSEcCtD
Ramipril—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000124	0.00331	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000124	0.00331	CcSEcCtD
Ramipril—Visual impairment—Furosemide—dilated cardiomyopathy	0.000123	0.00327	CcSEcCtD
Ramipril—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000122	0.00326	CcSEcCtD
Ramipril—Gastritis—Lisinopril—dilated cardiomyopathy	0.000122	0.00325	CcSEcCtD
Ramipril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00012	0.0032	CcSEcCtD
Ramipril—Asthma—Lisinopril—dilated cardiomyopathy	0.000119	0.00318	CcSEcCtD
Ramipril—Influenza—Lisinopril—dilated cardiomyopathy	0.000119	0.00318	CcSEcCtD
Ramipril—Tinnitus—Furosemide—dilated cardiomyopathy	0.000119	0.00316	CcSEcCtD
Ramipril—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000118	0.00315	CcSEcCtD
Ramipril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000118	0.00313	CcSEcCtD
Ramipril—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000117	0.00313	CcSEcCtD
Ramipril—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000117	0.00312	CcSEcCtD
Ramipril—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000116	0.00309	CcSEcCtD
Ramipril—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000116	0.00309	CcSEcCtD
Ramipril—Enalapril—ACE—dilated cardiomyopathy	0.000116	0.0713	CrCbGaD
Ramipril—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000115	0.00306	CcSEcCtD
Ramipril—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000115	0.00306	CcSEcCtD
Ramipril—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000114	0.00303	CcSEcCtD
Ramipril—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000114	0.00303	CcSEcCtD
Ramipril—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000113	0.00302	CcSEcCtD
Ramipril—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000112	0.00297	CcSEcCtD
Ramipril—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000111	0.00295	CcSEcCtD
Ramipril—Malnutrition—Furosemide—dilated cardiomyopathy	0.000111	0.00295	CcSEcCtD
Ramipril—Erythema—Furosemide—dilated cardiomyopathy	0.000111	0.00295	CcSEcCtD
Ramipril—Dizziness—Spironolactone—dilated cardiomyopathy	0.00011	0.00293	CcSEcCtD
Ramipril—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00011	0.00293	CcSEcCtD
Ramipril—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000109	0.0029	CcSEcCtD
Ramipril—Weight increased—Lisinopril—dilated cardiomyopathy	0.000109	0.00289	CcSEcCtD
Ramipril—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000109	0.00289	CcSEcCtD
Ramipril—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000107	0.00284	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000106	0.0154	CbGpPWpGaD
Ramipril—Vomiting—Spironolactone—dilated cardiomyopathy	0.000106	0.00281	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000106	0.00281	CcSEcCtD
Ramipril—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000105	0.00279	CcSEcCtD
Ramipril—Rash—Spironolactone—dilated cardiomyopathy	0.000105	0.00279	CcSEcCtD
Ramipril—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000105	0.00279	CcSEcCtD
Ramipril—Renal failure—Lisinopril—dilated cardiomyopathy	0.000105	0.00278	CcSEcCtD
Ramipril—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000104	0.00278	CcSEcCtD
Ramipril—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000104	0.00278	CcSEcCtD
Ramipril—Headache—Spironolactone—dilated cardiomyopathy	0.000104	0.00277	CcSEcCtD
Ramipril—Jaundice—Lisinopril—dilated cardiomyopathy	0.000104	0.00276	CcSEcCtD
Ramipril—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000103	0.00275	CcSEcCtD
Ramipril—Sweating—Lisinopril—dilated cardiomyopathy	0.000102	0.00272	CcSEcCtD
Ramipril—Agitation—Furosemide—dilated cardiomyopathy	0.000102	0.00271	CcSEcCtD
Ramipril—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000101	0.00268	CcSEcCtD
Ramipril—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0001	0.00267	CcSEcCtD
Ramipril—Sinusitis—Lisinopril—dilated cardiomyopathy	9.98e-05	0.00266	CcSEcCtD
Ramipril—Vertigo—Furosemide—dilated cardiomyopathy	9.96e-05	0.00265	CcSEcCtD
Ramipril—Agranulocytosis—Lisinopril—dilated cardiomyopathy	9.93e-05	0.00264	CcSEcCtD
Ramipril—Leukopenia—Furosemide—dilated cardiomyopathy	9.92e-05	0.00264	CcSEcCtD
Ramipril—Nausea—Spironolactone—dilated cardiomyopathy	9.88e-05	0.00263	CcSEcCtD
Ramipril—Hepatitis—Lisinopril—dilated cardiomyopathy	9.55e-05	0.00254	CcSEcCtD
Ramipril—Oedema peripheral—Lisinopril—dilated cardiomyopathy	9.41e-05	0.00251	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	9.37e-05	0.00249	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—TAZ—dilated cardiomyopathy	9.31e-05	0.0135	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	9.31e-05	0.0135	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.28e-05	0.0134	CbGpPWpGaD
Ramipril—Dry mouth—Furosemide—dilated cardiomyopathy	9.23e-05	0.00246	CcSEcCtD
Ramipril—Confusional state—Furosemide—dilated cardiomyopathy	9.12e-05	0.00243	CcSEcCtD
Ramipril—Anaphylactic shock—Furosemide—dilated cardiomyopathy	9.05e-05	0.00241	CcSEcCtD
Ramipril—Erythema multiforme—Lisinopril—dilated cardiomyopathy	9.03e-05	0.0024	CcSEcCtD
Ramipril—Tinnitus—Lisinopril—dilated cardiomyopathy	8.91e-05	0.00237	CcSEcCtD
Ramipril—Shock—Furosemide—dilated cardiomyopathy	8.9e-05	0.00237	CcSEcCtD
Ramipril—Nervous system disorder—Furosemide—dilated cardiomyopathy	8.87e-05	0.00236	CcSEcCtD
Ramipril—Flushing—Lisinopril—dilated cardiomyopathy	8.87e-05	0.00236	CcSEcCtD
Ramipril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	8.86e-05	0.00236	CcSEcCtD
Ramipril—Skin disorder—Furosemide—dilated cardiomyopathy	8.79e-05	0.00234	CcSEcCtD
Ramipril—Hyperhidrosis—Furosemide—dilated cardiomyopathy	8.74e-05	0.00233	CcSEcCtD
Ramipril—Anorexia—Furosemide—dilated cardiomyopathy	8.62e-05	0.0023	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.61e-05	0.0125	CbGpPWpGaD
Ramipril—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	8.61e-05	0.00229	CcSEcCtD
Ramipril—Arrhythmia—Lisinopril—dilated cardiomyopathy	8.53e-05	0.00227	CcSEcCtD
Ramipril—Hypotension—Furosemide—dilated cardiomyopathy	8.45e-05	0.00225	CcSEcCtD
Ramipril—Alopecia—Lisinopril—dilated cardiomyopathy	8.44e-05	0.00225	CcSEcCtD
Ramipril—Mental disorder—Lisinopril—dilated cardiomyopathy	8.37e-05	0.00223	CcSEcCtD
Ramipril—Malnutrition—Lisinopril—dilated cardiomyopathy	8.32e-05	0.00221	CcSEcCtD
Ramipril—Erythema—Lisinopril—dilated cardiomyopathy	8.32e-05	0.00221	CcSEcCtD
Ramipril—Tension—Lisinopril—dilated cardiomyopathy	8.16e-05	0.00217	CcSEcCtD
Ramipril—Dysgeusia—Lisinopril—dilated cardiomyopathy	8.14e-05	0.00217	CcSEcCtD
Ramipril—Paraesthesia—Furosemide—dilated cardiomyopathy	8.12e-05	0.00216	CcSEcCtD
Ramipril—Nervousness—Lisinopril—dilated cardiomyopathy	8.08e-05	0.00215	CcSEcCtD
Ramipril—Somnolence—Furosemide—dilated cardiomyopathy	8.04e-05	0.00214	CcSEcCtD
Ramipril—Muscle spasms—Lisinopril—dilated cardiomyopathy	8e-05	0.00213	CcSEcCtD
Ramipril—Decreased appetite—Furosemide—dilated cardiomyopathy	7.86e-05	0.00209	CcSEcCtD
Ramipril—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	7.81e-05	0.00208	CcSEcCtD
Ramipril—Fatigue—Furosemide—dilated cardiomyopathy	7.8e-05	0.00208	CcSEcCtD
Ramipril—Tremor—Lisinopril—dilated cardiomyopathy	7.79e-05	0.00207	CcSEcCtD
Ramipril—Constipation—Furosemide—dilated cardiomyopathy	7.74e-05	0.00206	CcSEcCtD
Ramipril—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	7.72e-05	0.00205	CcSEcCtD
Ramipril—Angioedema—Lisinopril—dilated cardiomyopathy	7.6e-05	0.00202	CcSEcCtD
Ramipril—Malaise—Lisinopril—dilated cardiomyopathy	7.5e-05	0.002	CcSEcCtD
Ramipril—Vertigo—Lisinopril—dilated cardiomyopathy	7.47e-05	0.00199	CcSEcCtD
Ramipril—Syncope—Lisinopril—dilated cardiomyopathy	7.46e-05	0.00199	CcSEcCtD
Ramipril—Feeling abnormal—Furosemide—dilated cardiomyopathy	7.45e-05	0.00198	CcSEcCtD
Ramipril—Leukopenia—Lisinopril—dilated cardiomyopathy	7.44e-05	0.00198	CcSEcCtD
Ramipril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	7.4e-05	0.00197	CcSEcCtD
Ramipril—Palpitations—Lisinopril—dilated cardiomyopathy	7.35e-05	0.00196	CcSEcCtD
Ramipril—Loss of consciousness—Lisinopril—dilated cardiomyopathy	7.31e-05	0.00195	CcSEcCtD
Ramipril—Cough—Lisinopril—dilated cardiomyopathy	7.26e-05	0.00193	CcSEcCtD
Ramipril—Urticaria—Furosemide—dilated cardiomyopathy	7.19e-05	0.00191	CcSEcCtD
Ramipril—Body temperature increased—Furosemide—dilated cardiomyopathy	7.15e-05	0.0019	CcSEcCtD
Ramipril—Abdominal pain—Furosemide—dilated cardiomyopathy	7.15e-05	0.0019	CcSEcCtD
Ramipril—Myalgia—Lisinopril—dilated cardiomyopathy	7.08e-05	0.00188	CcSEcCtD
Ramipril—Arthralgia—Lisinopril—dilated cardiomyopathy	7.08e-05	0.00188	CcSEcCtD
Ramipril—Chest pain—Lisinopril—dilated cardiomyopathy	7.08e-05	0.00188	CcSEcCtD
Ramipril—Anxiety—Lisinopril—dilated cardiomyopathy	7.06e-05	0.00188	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	7.03e-05	0.00187	CcSEcCtD
Ramipril—Discomfort—Lisinopril—dilated cardiomyopathy	7e-05	0.00186	CcSEcCtD
Ramipril—Dry mouth—Lisinopril—dilated cardiomyopathy	6.92e-05	0.00184	CcSEcCtD
Ramipril—Confusional state—Lisinopril—dilated cardiomyopathy	6.84e-05	0.00182	CcSEcCtD
Ramipril—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	6.79e-05	0.00181	CcSEcCtD
Ramipril—Oedema—Lisinopril—dilated cardiomyopathy	6.79e-05	0.00181	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	6.73e-05	0.00975	CbGpPWpGaD
Ramipril—Shock—Lisinopril—dilated cardiomyopathy	6.68e-05	0.00178	CcSEcCtD
Ramipril—Hypersensitivity—Furosemide—dilated cardiomyopathy	6.66e-05	0.00177	CcSEcCtD
Ramipril—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	6.65e-05	0.00177	CcSEcCtD
Ramipril—Tachycardia—Lisinopril—dilated cardiomyopathy	6.62e-05	0.00176	CcSEcCtD
Ramipril—Skin disorder—Lisinopril—dilated cardiomyopathy	6.59e-05	0.00175	CcSEcCtD
Ramipril—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	6.56e-05	0.00175	CcSEcCtD
Ramipril—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	6.56e-05	0.00951	CbGpPWpGaD
Ramipril—Asthenia—Furosemide—dilated cardiomyopathy	6.49e-05	0.00173	CcSEcCtD
Ramipril—Anorexia—Lisinopril—dilated cardiomyopathy	6.47e-05	0.00172	CcSEcCtD
Ramipril—Pruritus—Furosemide—dilated cardiomyopathy	6.4e-05	0.0017	CcSEcCtD
Ramipril—Hypotension—Lisinopril—dilated cardiomyopathy	6.34e-05	0.00169	CcSEcCtD
Ramipril—Diarrhoea—Furosemide—dilated cardiomyopathy	6.19e-05	0.00165	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	6.18e-05	0.00165	CcSEcCtD
Ramipril—Insomnia—Lisinopril—dilated cardiomyopathy	6.14e-05	0.00163	CcSEcCtD
Ramipril—Paraesthesia—Lisinopril—dilated cardiomyopathy	6.09e-05	0.00162	CcSEcCtD
Ramipril—Dyspnoea—Lisinopril—dilated cardiomyopathy	6.05e-05	0.00161	CcSEcCtD
Ramipril—Somnolence—Lisinopril—dilated cardiomyopathy	6.03e-05	0.00161	CcSEcCtD
Ramipril—Dizziness—Furosemide—dilated cardiomyopathy	5.98e-05	0.00159	CcSEcCtD
Ramipril—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.97e-05	0.00159	CcSEcCtD
Ramipril—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.9e-05	0.00157	CcSEcCtD
Ramipril—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	5.86e-05	0.00156	CcSEcCtD
Ramipril—Fatigue—Lisinopril—dilated cardiomyopathy	5.85e-05	0.00156	CcSEcCtD
Ramipril—Constipation—Lisinopril—dilated cardiomyopathy	5.8e-05	0.00155	CcSEcCtD
Ramipril—Vomiting—Furosemide—dilated cardiomyopathy	5.75e-05	0.00153	CcSEcCtD
Ramipril—Rash—Furosemide—dilated cardiomyopathy	5.7e-05	0.00152	CcSEcCtD
Ramipril—Dermatitis—Furosemide—dilated cardiomyopathy	5.7e-05	0.00152	CcSEcCtD
Ramipril—Headache—Furosemide—dilated cardiomyopathy	5.67e-05	0.00151	CcSEcCtD
Ramipril—Feeling abnormal—Lisinopril—dilated cardiomyopathy	5.59e-05	0.00149	CcSEcCtD
Ramipril—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	5.55e-05	0.00148	CcSEcCtD
Ramipril—Urticaria—Lisinopril—dilated cardiomyopathy	5.39e-05	0.00144	CcSEcCtD
Ramipril—Nausea—Furosemide—dilated cardiomyopathy	5.37e-05	0.00143	CcSEcCtD
Ramipril—Abdominal pain—Lisinopril—dilated cardiomyopathy	5.37e-05	0.00143	CcSEcCtD
Ramipril—Body temperature increased—Lisinopril—dilated cardiomyopathy	5.37e-05	0.00143	CcSEcCtD
Ramipril—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	5.24e-05	0.0076	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	5.03e-05	0.00729	CbGpPWpGaD
Ramipril—Hypersensitivity—Lisinopril—dilated cardiomyopathy	5e-05	0.00133	CcSEcCtD
Ramipril—Asthenia—Lisinopril—dilated cardiomyopathy	4.87e-05	0.0013	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.85e-05	0.00703	CbGpPWpGaD
Ramipril—Pruritus—Lisinopril—dilated cardiomyopathy	4.8e-05	0.00128	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.71e-05	0.00683	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.71e-05	0.00683	CbGpPWpGaD
Ramipril—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.64e-05	0.00124	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.6e-05	0.00667	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.5e-05	0.00652	CbGpPWpGaD
Ramipril—Dizziness—Lisinopril—dilated cardiomyopathy	4.49e-05	0.00119	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.38e-05	0.00635	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.38e-05	0.00634	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.38e-05	0.00634	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.33e-05	0.00627	CbGpPWpGaD
Ramipril—Vomiting—Lisinopril—dilated cardiomyopathy	4.32e-05	0.00115	CcSEcCtD
Ramipril—Rash—Lisinopril—dilated cardiomyopathy	4.28e-05	0.00114	CcSEcCtD
Ramipril—Dermatitis—Lisinopril—dilated cardiomyopathy	4.28e-05	0.00114	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	4.26e-05	0.00618	CbGpPWpGaD
Ramipril—Headache—Lisinopril—dilated cardiomyopathy	4.25e-05	0.00113	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.07e-05	0.0059	CbGpPWpGaD
Ramipril—Nausea—Lisinopril—dilated cardiomyopathy	4.03e-05	0.00107	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	3.74e-05	0.00542	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	3.74e-05	0.00542	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.67e-05	0.00531	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	2.05e-05	0.00297	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	2.01e-05	0.00291	CbGpPWpGaD
Ramipril—BCHE—Metabolism—TAZ—dilated cardiomyopathy	1.93e-05	0.00279	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SDHA—dilated cardiomyopathy	1.74e-05	0.00253	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.49e-05	0.00216	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	1.47e-05	0.00213	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	1.27e-05	0.00184	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	1.14e-05	0.00166	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.06e-05	0.00154	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.03e-05	0.0015	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.56e-06	0.00139	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.32e-06	0.00135	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.87e-06	0.00129	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	8.05e-06	0.00117	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GPX1—dilated cardiomyopathy	4.73e-06	0.000686	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CD36—dilated cardiomyopathy	4.61e-06	0.000668	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AGT—dilated cardiomyopathy	4.15e-06	0.000601	CbGpPWpGaD
